Global Hypodermic Needles Market By Products, By Application, By End Users : Global Opportunity Analysis and Industry Forecast, 2020-2030

Description

List of Tables

The global hypodermic needles market size was valued at $3,256.00 million in 2020, and is expected to garner $4,537.99 million by 2030, registering a CAGR of 3.4 % during the forecast period 2021-2030.

A hypodermic needle is a hollow needle widely used across medical settings to carry out different applications, such as drug delivery, vaccination, and blood specimen collection. These needles function through two different mechanisms, namely safety and non-safety needles. They are used to administer and inject drugs in the body and also to withdraw fluids from the body for examination and research purposes.

The growth of the global hypodermic needles market size is driven by increase in incidences of needlestick injuries. According to World Health Organization, it was estimated that 296 million people were living with chronic hepatitis B infection in 2019, with 1.5 million new infections each year in 2019. Hepatitis B resulted in an estimated 820, 000 deaths, and hundreds of thousands of healthcare workers were at high risk of work-related infections, such as hepatitis B, hepatitis C, and HIV due to exposure to contaminated needle sticks and sharp injuries. In addition, rise in incidence of chronic & lifestyle diseases, especially diabetes, supplements the hypodermic needles market growth. However, availability of alternative modes of drug delivery, low awareness towards safety syringes, and high cost of hypodermic needles hamper the hypodermic needles industry. Based on hypodermic needles market analysis, the untapped emerging economies present lucrative opportunities for the market.

The hypodermic needles market is segmented on the basis of product type, application, end user, and region. On the basis of product type, the market is bifurcated into safety and non-safety hypodermic needles. The safety hypodermic needles segment is sub-segmented on the basis of type and mode of activation.

By type, safety hypodermic needles are divided into retractable and nonretractable needles. By mode of activation, they are classified into active and passive hypodermic needles.

The safety hypodermic needle segment holds the largest market share owing to the technological advancements, prevention of needlestick injuries, and safety mechanisms embedded in these needles.

By applications, the market if divided into drug delivery, vaccination, and blood specimen collection. The drug delivery application was the highest revenue contributor in 2020. However, the vaccination segment is anticipated to grow at the highest rate during the forecast period owing to high birth rates and increase in awareness towards vaccination globally.

By end user, the hypodermic needles market includes hospitals, diabetic patient, family practitioner, psychiatry and others. World Health Organization (WHO) has recommended all healthcare providers to switch over to safer needles and helps prevent the spread of blood-borne diseases such as hepatitis, HIV, and viral hemorrhagic fevers. Hospitals are the largest end users of hypodermic needles. Hospitals that are publicly or privately owned, multinational hospitals, specialty hospitals, and others, widely use hypodermic needles for various purposes such as vaccination, drug delivery, blood specimen collection, and others.

Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Asia-Pacific accounted for the largest hypodermic needles market share in 2020, and is expected to maintain its dominance during the forecast period. This is attributed to higher buying power and stringent regulations that favor the utilization of hypodermic needles. In addition, increase in awareness towards the risk of cross infection (such as hepatitis, HIV, and AIDS) and needlestick injuries, boosts the adoption of safety hypodermic needles. Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to improvements in healthcare facilities, increase in disposable income, and rapid development of economic conditions.
The key players that operate in the global hypodermic needles market include, Becton, Dickinson and Company, B. Braun Melsungen Ag, Cardinal Health Inc., Connecticut Hypodermics Inc., Exelint International Co., Mckesson Corporation, Hi-tech syringes, Retractable Technologies, Inc., Nipro Corporation, and Terumo Medical Corporation.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global hypodermic needles market analysis from 2020 to 2030 to identify the prevailing global hypodermic needles market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the global hypodermic needles market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global global hypodermic needles market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Products

Safety Hypodermic Needles
Non-safety Hypodermic Needles

By Application

Drug Delivery
Vaccination
Blood Specimen Collection

By End Users

Hospital
Diabetic Patients
Family Practitioners
Psychiatry
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- "Rest Of Europe "
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan, Republic Of China
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Becton, Dickinson and Company
- B. BRAUN MELSUNGEN AG
- Cardinal Health Inc.
- CONNECTICUT HYPODERMICS INC.
- EXELINT INTERNATIONAL CO.
- McKesson Corporation
- Hitech Syringes
- Retractable Technologies, Inc.
- Nipro Corporation
- TERUMO MEDICAL CORPORATION

Product Code: A01538

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: GLOBAL HYPODERMIC NEEDLES MARKET, BY PRODUCTS

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Safety Hypodermic Needles
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
4.3 Non-safety Hypodermic Needles
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country

CHAPTER 5: GLOBAL HYPODERMIC NEEDLES MARKET, BY APPLICATION

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Drug Delivery
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
5.3 Vaccination
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
5.4 Blood Specimen Collection
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country

CHAPTER 6: GLOBAL HYPODERMIC NEEDLES MARKET, BY END USERS

6.1 Overview
- 6.1.1 Market size and forecast
6.2 Hospital
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
6.3 Diabetic Patients
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
6.4 Family Practitioners
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
6.5 Psychiatry
- 6.5.1 Key market trends, growth factors and opportunities
- 6.5.2 Market size and forecast, by region
- 6.5.3 Market analysis by country
6.6 Others
- 6.6.1 Key market trends, growth factors and opportunities
- 6.6.2 Market size and forecast, by region
- 6.6.3 Market analysis by country

CHAPTER 7: GLOBAL HYPODERMIC NEEDLES MARKET, BY REGION

7.1 Overview
- 7.1.1 Market size and forecast
7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Products
- 7.2.3 North America Market size and forecast, by Application
- 7.2.4 North America Market size and forecast, by End Users
- 7.2.5 North America Market size and forecast, by country
  - 7.2.5.1 U.S.
  - 7.2.5.1.1 Market size and forecast, by Products
  - 7.2.5.1.2 Market size and forecast, by Application
  - 7.2.5.1.3 Market size and forecast, by End Users
  - 7.2.5.2 Canada
  - 7.2.5.2.1 Market size and forecast, by Products
  - 7.2.5.2.2 Market size and forecast, by Application
  - 7.2.5.2.3 Market size and forecast, by End Users
  - 7.2.5.3 Mexico
  - 7.2.5.3.1 Market size and forecast, by Products
  - 7.2.5.3.2 Market size and forecast, by Application
  - 7.2.5.3.3 Market size and forecast, by End Users
7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Products
- 7.3.3 Europe Market size and forecast, by Application
- 7.3.4 Europe Market size and forecast, by End Users
- 7.3.5 Europe Market size and forecast, by country
  - 7.3.5.1 Germany
  - 7.3.5.1.1 Market size and forecast, by Products
  - 7.3.5.1.2 Market size and forecast, by Application
  - 7.3.5.1.3 Market size and forecast, by End Users
  - 7.3.5.2 France
  - 7.3.5.2.1 Market size and forecast, by Products
  - 7.3.5.2.2 Market size and forecast, by Application
  - 7.3.5.2.3 Market size and forecast, by End Users
  - 7.3.5.3 U.K.
  - 7.3.5.3.1 Market size and forecast, by Products
  - 7.3.5.3.2 Market size and forecast, by Application
  - 7.3.5.3.3 Market size and forecast, by End Users
  - 7.3.5.4 Italy
  - 7.3.5.4.1 Market size and forecast, by Products
  - 7.3.5.4.2 Market size and forecast, by Application
  - 7.3.5.4.3 Market size and forecast, by End Users
  - 7.3.5.5 Spain
  - 7.3.5.5.1 Market size and forecast, by Products
  - 7.3.5.5.2 Market size and forecast, by Application
  - 7.3.5.5.3 Market size and forecast, by End Users
  - 7.3.5.6 "Rest Of Europe "
  - 7.3.5.6.1 Market size and forecast, by Products
  - 7.3.5.6.2 Market size and forecast, by Application
  - 7.3.5.6.3 Market size and forecast, by End Users
7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Products
- 7.4.3 Asia-Pacific Market size and forecast, by Application
- 7.4.4 Asia-Pacific Market size and forecast, by End Users
- 7.4.5 Asia-Pacific Market size and forecast, by country
  - 7.4.5.1 Japan
  - 7.4.5.1.1 Market size and forecast, by Products
  - 7.4.5.1.2 Market size and forecast, by Application
  - 7.4.5.1.3 Market size and forecast, by End Users
  - 7.4.5.2 China
  - 7.4.5.2.1 Market size and forecast, by Products
  - 7.4.5.2.2 Market size and forecast, by Application
  - 7.4.5.2.3 Market size and forecast, by End Users
  - 7.4.5.3 Australia
  - 7.4.5.3.1 Market size and forecast, by Products
  - 7.4.5.3.2 Market size and forecast, by Application
  - 7.4.5.3.3 Market size and forecast, by End Users
  - 7.4.5.4 India
  - 7.4.5.4.1 Market size and forecast, by Products
  - 7.4.5.4.2 Market size and forecast, by Application
  - 7.4.5.4.3 Market size and forecast, by End Users
  - 7.4.5.5 South Korea
  - 7.4.5.5.1 Market size and forecast, by Products
  - 7.4.5.5.2 Market size and forecast, by Application
  - 7.4.5.5.3 Market size and forecast, by End Users
  - 7.4.5.6 Taiwan, Republic Of China
  - 7.4.5.6.1 Market size and forecast, by Products
  - 7.4.5.6.2 Market size and forecast, by Application
  - 7.4.5.6.3 Market size and forecast, by End Users
  - 7.4.5.7 Rest of Asia-Pacific
  - 7.4.5.7.1 Market size and forecast, by Products
  - 7.4.5.7.2 Market size and forecast, by Application
  - 7.4.5.7.3 Market size and forecast, by End Users
7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Products
- 7.5.3 LAMEA Market size and forecast, by Application
- 7.5.4 LAMEA Market size and forecast, by End Users
- 7.5.5 LAMEA Market size and forecast, by country
  - 7.5.5.1 Brazil
  - 7.5.5.1.1 Market size and forecast, by Products
  - 7.5.5.1.2 Market size and forecast, by Application
  - 7.5.5.1.3 Market size and forecast, by End Users
  - 7.5.5.2 Saudi Arabia
  - 7.5.5.2.1 Market size and forecast, by Products
  - 7.5.5.2.2 Market size and forecast, by Application
  - 7.5.5.2.3 Market size and forecast, by End Users
  - 7.5.5.3 South Africa
  - 7.5.5.3.1 Market size and forecast, by Products
  - 7.5.5.3.2 Market size and forecast, by Application
  - 7.5.5.3.3 Market size and forecast, by End Users
  - 7.5.5.4 Rest of LAMEA
  - 7.5.5.4.1 Market size and forecast, by Products
  - 7.5.5.4.2 Market size and forecast, by Application
  - 7.5.5.4.3 Market size and forecast, by End Users

CHAPTER 8: COMPANY LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES

9.1 Becton, Dickinson and Company
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
9.2 B. BRAUN MELSUNGEN AG
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
9.3 Cardinal Health Inc.
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
9.4 CONNECTICUT HYPODERMICS INC.
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
9.5 EXELINT INTERNATIONAL CO.
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
9.6 McKesson Corporation
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
9.7 Hitech Syringes
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
9.8 Retractable Technologies, Inc.
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
9.9 Nipro Corporation
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
9.10 TERUMO MEDICAL CORPORATION
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments